Assignee
RAPT THERAPEUTICS INC
US12 patents
Top patents by PatentIndex Score
US10683280B2Jun 16, 2020
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC8 citations82
US11384064B2Jul 12, 2022
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC3 citations71
US11192879B2Dec 7, 2021
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC3 citations71
US10604526B2Mar 31, 2020
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC2 citations71
US11046699B2Jun 29, 2021
Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
RAPT THERAPEUTICS INC3 citations65
US12098139B2Sep 24, 2024
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC0 citations60
US12428393B2Sep 30, 2025
Methods of making trans isomeric forms of G protein-coupled receptor modulators
RAPT THERAPEUTICS INC1 citations58
US12006318B2Jun 11, 2024
Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof
RAPT THERAPEUTICS INC0 citations58
US11084829B2Aug 10, 2021
Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
RAPT THERAPEUTICS INC2 citations58
US11730736B2Aug 22, 2023
Anticancer agents
RAPT THERAPEUTICS INC2 citations57
US12240837B2Mar 4, 2025
Chemokine receptor modulators and uses thereof
RAPT THERAPEUTICS INC0 citations50
US11918582B2Mar 5, 2024
Pyrazole pyrimidine compounds and uses thereof
RAPT THERAPEUTICS INC0 citations42